Holen Sie sich die Stockscreener-App
1.715
4.47%
-0.075
Schlusskurs vom Vortag:
$1.79
Offen:
$1.79
24-Stunden-Volumen:
109.93K
Relative Volume:
0.33
Marktkapitalisierung:
$53.66M
Einnahmen:
$1.05M
Nettoeinkommen (Verlust:
$-48.82M
KGV:
-0.9372
EPS:
-1.83
Netto-Cashflow:
$-47.49M
1W Leistung:
+1.18%
1M Leistung:
+20.42%
6M Leistung:
+32.56%
1J Leistung:
-78.13%
1-Tages-Spanne:
$1.70
$1.79
1-Wochen-Bereich:
$1.6301
$1.89
52-Wochen-Spanne:
$1.06
$7.9499
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Firmenname
Actinium Pharmaceuticals Inc
Sektor
Branche
Telefon
646-767-3870
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Vergleichen Sie ATNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.72 | 55.84M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.67 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.24 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.31 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
597.35 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.96 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-07 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Eingeleitet | B. Riley Securities | Buy |
| 2020-11-05 | Eingeleitet | Alliance Global Partners | Buy |
| 2017-12-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-14 | Eingeleitet | Maxim Group | Buy |
| 2016-08-25 | Eingeleitet | ROTH Capital | Buy |
| 2016-02-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2014-10-01 | Eingeleitet | MLV & Co | Buy |
| 2014-07-22 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
What are the latest earnings results for Actinium Pharmaceuticals Inc.Tremendous portfolio expansion - jammulinksnews.com
Can machine learning forecast Actinium Pharmaceuticals Inc. recoveryMarket Forecast Summary Over Multi-Year Period - Newser
What institutional flow reveals about Actinium Pharmaceuticals Inc.Long Term Stock Growth Plan Suggestions - Newser
How to interpret RSI for Actinium Pharmaceuticals Inc. stockFree Trade Insight With Community Collaboration - Newser
Using Bollinger Bands to evaluate Actinium Pharmaceuticals Inc. Quarterly Investment Outlook and Key Summary - Newser
What is the risk reward ratio of investing in Actinium Pharmaceuticals Inc. stockBreakout stock performance - jammulinksnews.com
Is it the right time to buy Actinium Pharmaceuticals Inc. stockUnprecedented profits - jammulinksnews.com
What is Actinium Pharmaceuticals Inc. company’s growth strategyFree Real-Time Stock Data - jammulinksnews.com
When is Actinium Pharmaceuticals Inc. stock expected to show significant growthGrow your wealth with proven stock picks - jammulinksnews.com
Why is Actinium Pharmaceuticals Inc. stock attracting strong analyst attentionExceptional portfolio growth - jammulinksnews.com
Actinium Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveFree Access to Community - Newser
Is Actinium Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Free Stock Market Real-Time Monitoring - Newser
Actinium Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowMassive Gain Ideas - Newser
Actinium Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsStrong Buy Recommendations - Newser
Is Actinium Pharmaceuticals Inc. stock a growth or value playProfessional Stock Screener - Newser
Key External Factors That Drive Actinium Pharmaceuticals Inc. Stock Price MovementsSmart Money Trade Setups - Newser
What institutions are buying Actinium Pharmaceuticals Inc. stock nowSuperior investment outcomes - jammulinksnews.com
What drives Actinium Pharmaceuticals Inc. stock priceAccelerated wealth expansion - PrintWeekIndia
Is Actinium Pharmaceuticals Inc. a good long term investmentRapid growth opportunities - Autocar Professional
What analysts say about Actinium Pharmaceuticals Inc. stockHigh-yield growth strategies - PrintWeekIndia
What analysts say about Actinium Pharmaceuticals Inc. stock outlookUnbelievable profit margins - jammulinksnews.com
Actinium Pharmaceuticals Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com
Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser
Lead Plaintiff Appointed in Actinium Pharmaceuticals Class Action - TradingView
How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser
What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser
Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):